chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 days after MMR (right thigh) and Varivax, Pediarix, HIB (left thigh) were given, patient developed papular rash around injection site on the right thigh. Over next 3 days, spread to left thigh, arms, perioral, full body. Fever also started about 5 days after shots given and lasted about 4 days. No URI symptoms. Seen in ED on day 4 of rash and told possible allergic reaction to shot and given Benadryl without resolution of symptoms.
Patient complained of feeling lightheaded and dizzy. EMT called and vital signs stable. BP 92/50 HR 77. Patient refused stated she was feeling better and refused to transport to hospital.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient waited 15 minutes after receiveing vaccine and felt fine, on the drive home the patient says she had some difficulty swallowing water that caused pain in her chest, then passed out momentarily, patient returned to the pharmacy where we checked her BP which was 107-67, patient mom was on the phone with her physician, monitored the patient for additional 10 minutes and patient said she felt well enough to return home.  Gave patient chocolate bar since she had not eaten anything.
No adverse affects occurred after the first vaccine was given on 02/24/2021.  After this dose, the vaccination site became red, swollen, warm, and painful approximately 18 hours afterwards.  Began placing a cold compress to the area.
Patient stated his right arm was very sore and painful, beginning later that evening after receiving the shot in the morning. He came in to have it looked at on 11/2/2018. The actual injection site looked fine, however, 3" down from the site his arm was pink to dark pink in color along the inside of his upper arm. The area measured 6" in length by 4" in width. Stated his arm was still very sore and hurts to move it. He had his flu shot the same day in the left arm and had no problems or pain.
-Symptoms 1) Sudden, 2) extreme pallor 3) Skin cold/clammy 4) increased pulse/decreased Blood pressure, Reaction 10:18, Left ambulatory 11:00am, no treatment.
shortness of breath chest pain respiratory failure with hypoxia multifocal pnuemonia
This spontaneous report as received from a registered nurse, refers to an unspecified number of patients, of an unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with improperly stored GARDASIL (strength, dosage, route, and lot# were not reported). None symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sore throat; Flu like symptoms; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and OROPHARYNGEAL PAIN (Sore throat) in a 71-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2023, the patient received third dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 14-Oct-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 15-Oct-2023, the patient experienced OROPHARYNGEAL PAIN (Sore throat). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and OROPHARYNGEAL PAIN (Sore throat) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Patient received first dose of vaccine on 09Mar2021 with lot number EN6199 and second dose of vaccine on 30Mar2021 with lot number EN6204. With second dose, patient experienced pain at the injection site. On 14-Oct-2023, patient experienced flu like symptoms all day. On 15-Oct-2023, he felt better but that evening he had sore throat. He was feeling okay from 16-18Oct2023 but when he woke up on 19-Oct-2023 he again had sore throat. He feels that the flu like symptoms were back but was less worse than 14-Oct-2023. Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-746446 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-746446:Wife case
Patient reported to our onsite RN that after 24 hours of receiving the vaccine, she developed a fever, rash and soreness at the injection site (left deltoid).  This lasted 2 1/2 days and then  resolved.  On 23MAR21 at 0600, the patient felt a knot in her left arm, it was hot to touch and the rash reappeared.  As of 24MAR21, the pain and heat has subsided but the rash remains.
Nurse went to vaccinate child with mom holding.  Child moved, needle slipped back out.  No vaccine administered per RN.  The administering RN changed the needle and administered the dose to the patient with both parents securing the child successfully the second attempt.
itchiness at the injection site; Redness at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Sensitive skin.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications product use was not reported.  Treatment information included cold compress.
19OCT-12Noon-4PM screamed fell asleep-awoke screaming; no appetite; didn't ck temp 19OCT 20OCT t101 R 8AM; 20OCT93 sleeping alot; no temp; awoke; eat-falls asleep; responds to stimuli;
Became dizzy immediately after receiving intranasal H1N1 vaccine. Transported to ER where BP was monitored for a few hours. Was told she had a vagal response.
Redness; Hot to the touch at the area of injection; Hot to the touch; Mild fever; Lymph node aches; Muscle aches; This case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In October 2022, the patient received Shingles vaccine. In October 2022, less than a week after receiving Shingles vaccine, the patient experienced injection site erythema, injection site warmth, touch sensitivity increased, fever, lymph node pain and muscle pain. On an unknown date, the outcome of the injection site erythema, injection site warmth, touch sensitivity increased, fever, lymph node pain and muscle pain were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site warmth, touch sensitivity increased, fever, lymph node pain and muscle pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 23-OCT-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received dose of Shingles vaccine 5 days ago from the date of reporting, still had redness, hot to the touch at the area of the injection. The patient also experienced mild fever and lymph node and muscle aches continue. The patient asked was this normal. Additional supportive information: The follow-up would not possible, as no contact, details were available.
never received the second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly male patient who received HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix B (on 14th May 2022 received 1st dose with batch no 4EA77 and expiry date 11-SEP-2022.).   On an unknown date, the patient did not received the 2nd dose of Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incomplete course of vaccination (Verbatim: never received the second dose). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt date: 03-AUG-2023 A pharmacist reported that a patient received first dose of Engerix-B on 14May2022 and never received the second dose. At the time of reporting, no further doses had administered.  Till the time of reporting the patient had not received the second dose of Engerix-B, which led to incomplete course of vaccination. The VAERS details reported for 1st dose.  The reporter consented to follow up.
TREMBLING; BODY ACHES; NIGHTMARES; SEVERE CHILLS; SORE / PAINFUL ARM; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included type 2 diabetes, and other pre-existing medical conditions included patient had no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1820095, expiry: UNKNOWN) dose was not reported, administered on 28-JUN-2021 14:00 for prophylactic vaccination. No concomitant medications were reported. On 24-JUN-2021, Laboratory data included: COVID-19 antigen test (NR: not provided) Negative. On 28-JUN-2021, the subject experienced sore / painful arm. On 29-JUN-2021, the subject experienced trembling. On 29-JUN-2021, the subject experienced body aches. On 29-JUN-2021, the subject experienced nightmares. On 29-JUN-2021, the subject experienced severe chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from trembling, nightmares, and severe chills on 29-JUN-2021, and body aches on 30-JUN-2021, and had not recovered from sore / painful arm. This report was non-serious.
pt screaming for hours, still crying much 21May90 & 19Jun90.  Parents report still not sleeping well at night, pt appears otherwise healthy now
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 05-JUN-2008, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a clinic, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 21-APR-2015, the patient was treated at the clinic by a physician for a blistering vesicular outbreak, which was diagnosed as shingles. The patient was prescribed VALTREX and oxycodone for management of her painful symptoms and chronic pain. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
lethargic; sore throat; headache; body aches; tired; chills; This is a spontaneous report from a contactable consumer . A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection,)via an unspecified route of administration on 12Feb2021 16:45 ( as SINGLE DOSE for covid-19 immunisation .The patient medical history was not reported.The patient's concomitant medications were not reported.chills on 12Feb2021 and, headache on 13Feb2021 and body aches on 13Feb2021 and, tired on 13Feb2021 and, sore throat on 14Feb2021 and, lethargic  on an unspecified date and The patient underwent lab tests and procedures which included sars-cov-2 test: negative  on 15Feb2021 streptococcus test: negative  on 15Feb2021 and I have been taking ibuprofen and Tylenol and tacking Cepachol to help with the headaches and sore throat but as I am typing this both of these symptoms and lethargic still exist. When I was at urgent care, the nurse did say that side effects/symptoms can last 4-5 days. and outcome of the events for chills and pain and fatigue was unknown and headache and lethargic was not recovered
11/16/2005 9:00am received vaccines (DTaP, OPV, MMR, Flu) 7:10 am started with tight coriza, 9:20 am hives started appearing 9:30 transport to ER via EMT.
REDNESS,SWELLING, INDURATION 10MM, NECK AND L SHOULDER PAIN 6/10, BODY ACHES. NORMAL TEMP 98.6.SENT TO URGENT CARE.
vaccine did not work, shingles again/suspected Vaccination Failure; Shingles; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In September 2018, the patient received the 2nd dose of Shingrix. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, more than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were reported as follows: The case was reported by the patient. The patient reported that the Shingrix vaccine did not work as she suffered from shingles again (date unknown) and would like to know if she could get the vaccine again. The reporter did not mention anything regarding the shingles outbreak occurring in the specified country or outside of the specified country, only that she had an outbreak. The reporter consented to contact healthcare professional. The reporter consented to follow up. This case was considered as suspected vaccination failure as time to onset and laboratory confirmation for shingles were unknown at the time of reporting. For the shingles episodes experienced in other specified country, refer case CA2021218608.; Sender's Comments:  US-GLAXOSMITHKLINE-CA2021218608:Same reporter
pt recvd vax 10NOV03 pt returned to clinic on 12NOV93 for PPD; pt rt knee & thigh were swollen & red w/difficulty in walking;
Dizziness the next day, fainted, nausea, pain in injection sight, hurts to move arm
Had vaccination at approximately 10:30am., on 7/31/2021. At 2:00 am on 8/1/2021, pt reports he had diarrhea which continues until today. He states that he has taken 2 rounds of two weeks of antibiotics.  He can not tell me what antibiotic he has taken or who prescribed the antibiotic.
1st day I was a bit drowsy and heavy in my head; 1st day I was a bit drowsy and heavy in my head; Headache; This is a spontaneous report received from a contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 1 via an unspecified route of administration on 08Apr2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that 1st day patient was a bit drowsy and heavy in his head, then on the 2nd day he had a headache and took Tylenol. Then the next day there was heaviness again on his head. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Approached pharmacy and asked if I could receive my 2nd COVID shot as a walk in. The lead pharmacist tech replied " yes, do you have your vaccination card?" I provided my vaccination card to them. I finished some basic health history questions and address information, and then was instructed to sit down "behind the curtain." Lead pharmacist tech shortly arrived. Gave me the vaccination in my left deltoid and instructed me to wait 15 mins. I waited 15 mins. The lead pharmacy tech then came back after 15 mins and gave me my vaccination card and said "you are good to go." I then noticed on my vaccination card that it said "pfizer" for my second dose." I asked if this was a mistake as I was suppose to receive "moderna". She looked at my card and stated " oh." She then asked the Pharmacist on what to do. The pharmacist stated " You are not suppose to mix vaccination brands. He was suppose to receive Moderna. Oh  well, too late now. "
This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 68, via an unspecified route of administration, left arm, on Mar 11, 2021, at 09:00, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously took Penicillin G (benzylpenicillin), for unspecified indication on unknown date; and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in 2021, at 06:00, patient experienced a frozen shoulder and was in physical therapy. The injection site was still sore at the time of report. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures taken as a result of a frozen shoulder included physical therapy for four weeks; and has at least four more to go (twice a week). Since the vaccination, patient has not  tested for COVID-19. The outcome of frozen shoulder and sore injection site sore: not recovered (at the time of this report). No follow-up attempts needed. Information about lot/batch number cannot be obtained.
This spontaneous report as received from a office manager(healthcare prof-other) refers to a patient of unknown age. The patient, on 11-OCT-2012, was subcutaneously vaccinated with 0.65 ml of ZOSTAVAX (lot # 671018/0748AA) that expired 18-AUG-2012. The patient was not experiencing any known symptoms. The outcome was unknown. Additional information has been requested.
Patient reported to the pharmacy complaining of stiffness and swelling in the left arm following vaccination.  He was seem at the ER and had an MRI.  He stated  the MD told him that there was nothing remarkable on the report and did not give a reason for the complaint of the patient
Staff member experienced a fever of 101.7 and chills through the evening. Symptoms then resolved.
09/13/2022 I came down with COVID-19. I was exposed by my spouse. My symptoms were rhinitis and a sore throat. I tested with an at home COVID-19 test and it came out positive. I was prescribed PAXLOVID and my symptoms went away around 24 hours. 10 days later my symptoms came back and they dragged on for about 21 days. I did develop a mildly productive cough with no shortness of breath or wheezing. I am feeling much better and am now back to my normal self.
The patient's right upper arm (anterior) is swollen, erythemic, and sore below the injection site; within 12 -14 hours after the injection.
Patient had throat swelling potentially difficulty swallowing. Patient was given Benadryl and patient improved. Reaction occurred 30 minutes after dose. Patient has history of allergies and Asthma and had similar reaction to peanut in past. Vital signs were all stable throughout the course. Patient will follow up with physician allergist this week
I've occasionally had foot pain likely related to my psorarisis/psorariatic arthritis. Specifically my right foot, usually the ball of the foot by my big toe.   I woke up this morning with the most painful flareup I can recall. On a scale of 1-10, the pain was a 7-8. After taking two Aleve tablets and icing my foot twice the pain is a 3-4. The joint still feels swollen and the range of motion is diminished.
Patient developed erythema about a week post injection at the site, 1.5 X 2.5 inches. She was instructed to seek medical intervention in the ED
There is redness at injection site and small knot that has continued to be visible since the injection. Patient returned 7/1/17 to report.
Mild inflammation with minimal swelling and tenderness in my right parotid gland; Mild inflammation with minimal swelling and tenderness in my right parotid gland; Mild inflammation with minimal swelling and tenderness in my right parotid gland; Mild swelling and tenderness in lymph node on right at my mandibular angle.; Mild swelling and tenderness in lymph node on right at my mandibular angle.; 3rd booster dose; This is a spontaneous report from a contactable physician, the patient. A 72-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 27Aug2021 at 19:00 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin b complex (MANUFACTURER UNKNOWN), ubidecarenone (COQ10), cyanocobalamin (VITAMIN B-12), vitamin d nos (MANUFACTURER UNKNOWN), levoglutamide (GLUTAMINE), ascorbic acid (VITAMIN C) and fish oil (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 13Dec2020 at 14:00 (at the age of 71-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EKS730) via an unspecified route of administration in the right arm on 13Jan2021 at 14:00 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Sep2021, about 2 weeks after booster dose, the patient experienced mild inflammation with minimal swelling and tenderness in his right parotid gland and mild swelling and tenderness in lymph node on right at his mandibular angle. It has slowly improved over the next 2-3 weeks. On 04Oct2021, the patient underwent rapid antigen test via nasal swab and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events mild inflammation with minimal swelling and tenderness in his right parotid gland and mild swelling and tenderness in lymph node on right at his mandibular angle was resolving at the time of this report.
ZOSTAVAX was injected erroneously intramuscularly (correct IZ subcutaneous)